Total Visits

Views
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib886

Total Visits Per Month

April 2019May 2019June 2019July 2019August 2019September 2019October 2019
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinib517162521

File Visits

Views
article.pdf598

Top country views

Views
United Kingdom71
United States47
Germany40
France35
Norway5
Canada3
China3
Czech Republic1
South Korea1
Russia1

Top cities views

Views
Southend71
Ashburn34
Oslo4
Ann Arbor3
Montréal3
Beijing2
Mountain View2
University Park2
Boardman1
Cape Town1